Mid Atlantic Financial Management’s Travelers Companies TRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$352K Sell
2,315
-473
-17% -$73.2K 0.02% 596
2021
Q2
$417K Sell
2,788
-671
-19% -$104K 0.03% 541
2021
Q1
$520K Buy
3,459
+1,396
+68% +$205K 0.04% 416
2020
Q4
$290K Buy
2,063
+165
+9% +$21.2K 0.02% 592
2020
Q3
$255K Sell
1,898
-133
-7% -$15.2K 0.02% 580
2020
Q2
$232K Sell
2,031
-181
-8% -$19.1K 0.02% 576
2020
Q1
$220K Sell
2,212
-1,066
-33% -$133K 0.03% 537
2019
Q4
$449K Buy
3,278
+74
+2% +$10.1K 0.04% 418
2019
Q3
$476K Sell
3,204
-710
-18% -$106K 0.05% 366
2019
Q2
$585K Sell
3,914
-223
-5% -$32.2K 0.06% 332
2019
Q1
$567K Sell
4,137
-46
-1% -$5.88K 0.06% 328
2018
Q4
$501K Buy
+4,183
New +$524K 0.06% 331

Other funds holding TRV

Mid Atlantic Financial Management's TRV Position: Q3 2021 in Review

Mid Atlantic Financial Management reduced its Travelers Companies (TRV) stake by 17% in Q3 2021, selling an estimated $73.2K and leaving 2,315 shares worth $352K. The position accounts for 0.02% of the portfolio, ranked #596.

Mid Atlantic Financial Management first reported a position in TRV in Q4 2018 and has held it in 12 quarters since. The position peaked at $585K in Q2 2019. 1,128 funds tracked by Wall St. Rank hold TRV as of Q3 2021.

  • Mid Atlantic Financial Management held 2,315 shares of Travelers Companies worth $352K as of Q3 2021.
  • Mid Atlantic Financial Management sold 473 Travelers Companies shares in Q3 2021, an estimated $73.2K.
  • Travelers Companies made up 0.02% of Mid Atlantic Financial Management's portfolio in Q3 2021, its #596 holding.
  • Mid Atlantic Financial Management first reported a position in Travelers Companies in Q4 2018 and has held it in 12 quarters since.
  • Mid Atlantic Financial Management's Travelers Companies position peaked at $585K in Q2 2019.
  • 1,128 funds tracked by Wall St. Rank held Travelers Companies as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.